|
Volumn 29, Issue 4, 2002, Pages 486-493
|
Local injection of the 90Y-labelled peptidic vector DOTATOC to control gliomas of WHO grades II and III: An extended pilot study
|
Author keywords
Gliomas; Local injection; Peptidic receptor targeting; Yttrium 90 labelled octreotide
|
Indexed keywords
FLUORODEOXYGLUCOSE F 18;
OCTREOTIDE[DEXTRO 1 PHENYLALANINE 3 TYROSINE 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID] Y 90;
RADIOPHARMACEUTICAL AGENT;
UNCLASSIFIED DRUG;
DOTATOC YTTRIUM 90;
YTTRIUM 90;
(DOTA(0) PHE(1) TYR(3))OCTREOTIDE;
(DOTA(0)-PHE(1)-TYR(3))OCTREOTIDE;
DIAGNOSTIC AGENT;
DRUG DERIVATIVE;
OCTREOTIDE;
SOMATOSTATIN RECEPTOR;
YTTRIUM;
ADULT;
ANAPLASTIC CARCINOMA;
ARTICLE;
CANCER CONTROL;
CANCER GRADING;
CANCER INHIBITION;
CANCER RADIOTHERAPY;
CLINICAL ARTICLE;
CLINICAL FEATURE;
CONTROLLED STUDY;
DOSE CALCULATION;
DRUG RESPONSE;
DRUG TARGETING;
ELECTRON BEAM;
FEMALE;
FOLLOW UP;
GLIOBLASTOMA;
GLIOMA;
HUMAN;
ISOTOPE LABELING;
MALE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PILOT STUDY;
POSITRON EMISSION TOMOGRAPHY;
RADIATION DOSE;
RADIOISOTOPE THERAPY;
BRACHYTHERAPY;
ADJUVANT THERAPY;
AGED;
BRAIN TUMOR;
CLASSIFICATION;
CLINICAL TRIAL;
COMPARATIVE STUDY;
FEASIBILITY STUDY;
INTRALESIONAL DRUG ADMINISTRATION;
METHODOLOGY;
MIDDLE AGED;
RADIATION RESPONSE;
SCINTISCANNING;
SENSITIVITY AND SPECIFICITY;
TREATMENT OUTCOME;
WORLD HEALTH ORGANIZATION;
ADULT;
AGED;
BRACHYTHERAPY;
BRAIN NEOPLASMS;
DOSE-RESPONSE RELATIONSHIP, RADIATION;
FEASIBILITY STUDIES;
FEMALE;
FLUORODEOXYGLUCOSE F18;
FOLLOW-UP STUDIES;
GLIOMA;
HUMANS;
INJECTIONS, INTRALESIONAL;
MAGNETIC RESONANCE IMAGING;
MALE;
MIDDLE AGED;
OCTREOTIDE;
PILOT PROJECTS;
RADIOPHARMACEUTICALS;
RADIOTHERAPY DOSAGE;
RADIOTHERAPY, ADJUVANT;
RECEPTORS, SOMATOSTATIN;
SENSITIVITY AND SPECIFICITY;
TREATMENT OUTCOME;
WORLD HEALTH ORGANIZATION;
YTTRIUM RADIOISOTOPES;
|
EID: 0036546961
PISSN: 03406997
EISSN: None
Source Type: Journal
DOI: 10.1007/s00259-001-0717-x Document Type: Article |
Times cited : (80)
|
References (25)
|